A Phase I, Single Center Trial of Adoptive Immunotherapy With T-reg Adoptive Cell Transfer (TRACT) to Prevent Rejection in Living Donor Kidney Transplant Recipients
Phase of Trial: Phase I
Latest Information Update: 20 Apr 2017
At a glance
- Drugs CD4+ CD25+ Treg cells (Primary)
- Indications Renal transplant rejection
- Focus Adverse reactions; First in man
- 29 Jul 2016 Results of this trial were presented at the American Transplant Congress 2016, according to a Tract Therapeutics media release.
- 24 Jul 2015 New trial record
- 22 Jul 2015 According to a Tract Therapeutics media release, safety data from this trial were presented at the American Transplant Congress Meeting.